相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Lipophilic Purine Nucleoside-Tdp1 Inhibitor-Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo
Irina A. Chernyshova et al.
MOLECULES (2023)
New Deoxycholic Acid Derived Tyrosyl-DNA Phosphodiesterase 1 Inhibitors Also Inhibit Tyrosyl-DNA Phosphodiesterase 2
Oksana V. Salomatina et al.
MOLECULES (2022)
Pyranodipyran Derivatives with Tyrosyl DNA Phosphodiesterase 1 Inhibitory Activities and Fluorescent Properties from Aspergillus sp. EGF 15-0-3
Xia Wei et al.
MARINE DRUGS (2022)
Adamantane-Monoterpenoid Conjugates Linked via Heterocyclic Linkers Enhance the Cytotoxic Effect of Topotecan
Aldar A. Munkuev et al.
MOLECULES (2022)
In Vitro and In Silico Studies of Human Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) Inhibition by Stereoisomeric Forms of Lipophilic Nucleosides: The Role of Carbohydrate Stereochemistry in Ligand-Enzyme Interactions
Nadezhda S. Dyrkheeva et al.
MOLECULES (2022)
Dehydroabietylamine-based thiazolidin-4-ones and 2-thioxoimidazolidin-4-ones as novel tyrosyl-DNA phosphodiesterase 1 inhibitors
Kseniya Kovaleva et al.
MOLECULAR DIVERSITY (2021)
Deoxycholic acid as a molecular scaffold for tyrosyl-DNA phosphodiesterase 1 inhibition: A synthesis, structure-activity relationship and molecular modeling study
Oksana V. Salomatina et al.
STEROIDS (2021)
New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1
Nadezhda S. Dyrkheeva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Antitumor Activity of the Combination of Topotecan and Tyrosyl-DNA-Phosphodiesterase 1 Inhibitor on Model Krebs-2 Mouse Ascite Carcinoma
N. S. Dyrkheeva et al.
MOLECULAR BIOLOGY (2021)
Discovery of Novel Sultone Fused Berberine Derivatives as Promising Tdp1 Inhibitors
Elizaveta D. Gladkova et al.
MOLECULES (2021)
The benzylisoquinoline alkaloids, berberine and coptisine, act against camptothecin-resistant topoisomerase I mutants
Naomi Inoue et al.
SCIENTIFIC REPORTS (2021)
Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties
Kseniya Kovaleva et al.
PHARMACEUTICALS (2021)
The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo
V. P. Nikolin et al.
CLINICAL & EXPERIMENTAL METASTASIS (2021)
Novel Tdp1 Inhibitors Based on Adamantane Connected with Monoterpene Moieties via Heterocyclic Fragments
Aldar A. Munkuev et al.
MOLECULES (2021)
New Hybrid Compounds Combining Fragments of Usnic Acid and Monoterpenoids for Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibition
Nadezhda S. Dyrkheeva et al.
BIOMOLECULES (2021)
Identification of novel inhibitors for the tyrosyl-DNA-phosphodiesterase 1 (Tdp1) mutant SCAN1 using virtual screening
E. M. Mamontova et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy
Tatyana M. Khomenko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Usnic Acid Conjugates with Monoterpenoids as Potent Tyrosyl-DNA Phosphodiesterase 1 Inhibitors
Olga Luzina et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Design, Synthesis, and Biological Investigation of Novel Classes of 3-Carene-Derived Potent Inhibitors of TDP1
Irina Il'ina et al.
MOLECULES (2020)
Inhibition of Tyrosyl-DNA Phosphodiesterase 1 by Lipophilic Pyrimidine Nucleosides
Alexandra L. Zakharenko et al.
MOLECULES (2020)
The First Berberine-Based Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), an Important DNA Repair Enzyme
Elizaveta D. Gladkova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Inhibitory Effect of New Semisynthetic Usnic Acid Derivatives on Human Tyrosyl-DNA Phosphodiesterase 1
Nadezhda Dyrkheeva et al.
PLANTA MEDICA (2019)
Antimetastatic Activity of Combined Topotecan and Tyrosyl-DNA Phosphodiesterase-1 Inhibitor on Modeled Lewis Lung Carcinoma
E. V. Koldysheva et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
Dual DNA topoisomerase 1 and tyrosyl-DNA phosphodiesterase 1 inhibition for improved anticancer activity
Alexandra Zakharenko et al.
MEDICINAL RESEARCH REVIEWS (2019)
The Development of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors. Combination of Monoterpene and Adamantine Moieties via Amide or Thioamide Bridges
Arina A. Chepanova et al.
APPLIED SCIENCES-BASEL (2019)
Dehydroabietylamine Ureas and Thioureas as Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Enhance the Antitumor Effect of Temozolomide on Glioblastoma Cells
Kseniya Kovaleva et al.
JOURNAL OF NATURAL PRODUCTS (2019)
The first small fluorescent probe as Tyrosyl-DNA phosphodiesterase 1 (TDP1) substrate
Zhan-Yong Tang et al.
DYES AND PIGMENTS (2019)
New Hydrazinothiazole Derivatives of Usnic Acid as Potent Tdp1 Inhibitors
Aleksander S. Filimonov et al.
MOLECULES (2019)
Novel Inhibitors of DNA Repair Enzyme TDP1 Combining Monoterpenoid and Adamantane Fragments
Evgcnii S. Mozhaitsev et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)
Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topotecan on in vivo tumor models
A. L. Zakharenko et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
The Development of Tyrosyl-DNA Phosphodyesterase 1 (TDP1) Inhibitors Based on the Amines Combining Aromatic/Heteroaromatic and Monoterpenoid Moieties
Evgenii Mozhaitsev et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2019)
Effective Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 Based on Monoterpenoids as Potential Agents for Antitumor Therapy
A. A. Chepanova et al.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY (2019)
Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors
Konstantin Yu. Ponomarev et al.
BIOORGANIC CHEMISTRY (2018)
Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors
Oksana V. Salomatina et al.
MOLECULES (2018)
Synthesis and evaluation of aryliden- and hetarylidenfuranone derivatives of usnic acid as highly potent Tdp1 inhibitors
Olga Zakharova et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
SYNTHESIS AND INHIBITORY PROPERTIES OF IMINES CONTAINING MONOTERPENOID AND ADAMANTANE FRAGMENTS AGAINST DNA REPAIR ENZYME TYROSYL-DNA PHOSPHODIESTERASE 1 (Tdp1)
A. L. Zakharenko et al.
CHEMISTRY OF NATURAL COMPOUNDS (2018)
Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy
Anastasia O. Komarova et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
A Novel Class of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Contains the Octahydro-2H-chromen-4-ol Scaffold
Nikolai S. Li-Zhulanov et al.
MOLECULES (2018)
Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents
Xiao-Ru Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Alpha-terpineol affects synthesis and antitumor activity of triterpenoids from Antrodia cinnamomea mycelia in solid-state culture
Yutian Zhang et al.
FOOD & FUNCTION (2018)
Usnic Acid Derivatives Are Effective Inhibitors of Tyrosyl-DNA Phosphodiesterase 1
A. L. Zakharenko et al.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY (2017)
Identification of Natural Products That Inhibit the Catalytic Function of Human Tyrosyl-DNA Phosphodiesterase (TDP1)
Alun Bermingham et al.
SLAS DISCOVERY (2017)
Achyrodimer F, a tyrosyl-DNA phosphodiesterase I inhibitor from an Australian fungus of the family Cortinariaceae
Li-Wen Tian et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties
Tatyana Khomenko et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential
Sergey S. Laev et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of Camptothecin
Alexandra Zakharenko et al.
JOURNAL OF NATURAL PRODUCTS (2016)
Overexpression screens identify conserved dosage chromosome instability genes in yeast and human cancer
Supipi Duffy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Biological activity of usnic acid and its derivatives: Part 2. effects on higher organisms. Molecular and physicochemical aspects
O. A. Luzina et al.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY (2016)
Biological activity of usnic acid and its derivatives: Part 1. Activity against unicellular organisms
O. A. Luzina et al.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY (2016)
Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety
Alexandra Zakharenko et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Tyrosyl-DNA Phosphodiesterase I Inhibitors from the Australian Plant Macropteranthes leichhardtii
Li-Wen Tian et al.
JOURNAL OF NATURAL PRODUCTS (2015)
Inhibitory properties of nitrogen-containing adamantane derivatives with monoterpenoid fragments against tyrosyl-DNA phosphodiesterase 1
A. L. Zakharenko et al.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY (2015)
Development of an oligonucleotide-based fluorescence assay for the identification of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors
Sarah Walker et al.
ANALYTICAL BIOCHEMISTRY (2014)
Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2)
Yves Pommier et al.
DNA REPAIR (2014)
Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target
Evan Q. Comeaux et al.
DRUG METABOLISM REVIEWS (2014)
Targeting Multiple Key Signaling Pathways in Melanoma Using Leelamine
Raghavendra Gowda et al.
MOLECULAR CANCER THERAPEUTICS (2014)
TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy
Meryem Alagoz et al.
NUCLEIC ACIDS RESEARCH (2014)
Identification of a Putative Tdp1 Inhibitor (CD00509) by in Vitro and Cell-Based Assays
Richard A. Dean et al.
JOURNAL OF BIOMOLECULAR SCREENING (2014)
Real-time detection of TDP1 activity using a fluorophore-quencher coupled DNA-biosensor
Pia W. Jensen et al.
BIOSENSORS & BIOELECTRONICS (2013)
TDP1 and PARP1 Deficiency Are Cytotoxic to Rhabdomyosarcoma Cells
Hok Khim Fam et al.
MOLECULAR CANCER RESEARCH (2013)
Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition
Paola Perego et al.
BIOCHEMICAL PHARMACOLOGY (2012)
DNA Repair and Resistance to Topoisomerase I Inhibitors: Mechanisms, Biomarkers and Therapeutic Targets
M. Alagoz et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Repairs DNA Damage Induced by Topoisomerases I and II and Base Alkylation in Vertebrate Cells
Junko Murai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Tyrosyl-DNA Phosphodiesterase 1 Inhibitor from an Anamorphic Fungus
Motoki Takagi et al.
JOURNAL OF NATURAL PRODUCTS (2012)
Berberine: a potential phytochemical with multispectrum therapeutic activities
Parameswara Rao Vuddanda et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Impact of Natural Products on Developing New Anti-Cancer Agents
Gordon M. Cragg et al.
CHEMICAL REVIEWS (2009)
Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin
Sherif F. El-Khamisy et al.
DNA REPAIR (2009)
Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK
Benu Brata Das et al.
EMBO JOURNAL (2009)
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and Related Novel Steroid Derivatives as Tyrosyl-DNA Phosphodiesterase (Tdp1) Inhibitors
Thomas S. Dexheimer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay
Christophe Marchand et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Processing of nonconventional DNA strand break ends
David M. Wilson
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2007)
Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation?
Ryuki Hirano et al.
EMBO JOURNAL (2007)
TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo
Sachin Katyal et al.
EMBO JOURNAL (2007)
DNA single-strand break repair and spinocerebellar ataxia with axonal neuropathy-1
S. F. El-Khamisy et al.
NEUROSCIENCE (2007)
Increased expression and activity of repair genes TDP1 and XPF in non-small cell lung cancer
Chunyan Liu et al.
LUNG CANCER (2007)
Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1
Smitha Antony et al.
NUCLEIC ACIDS RESEARCH (2007)
Nucleoside transporters: from scavengers to novel therapeutic targets
Anne E. King et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Inhibition of human tyrosyl-DNA phosphodiesterase by aminoglycoside antibiotics and ribosome inhibitors
Zhiyong Liao et al.
MOLECULAR PHARMACOLOGY (2006)
Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage
Karin C. Nitiss et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
SCAN1 mutant Tdp1 accumulates the enzyme-DNA intermediate and causes camptothecin hypersensitivity
H Interthal et al.
EMBO JOURNAL (2005)
Gene expression profiling of the irinotecan pathway in colorectal cancer
JS Yu et al.
CLINICAL CANCER RESEARCH (2005)
Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase
MC Nivens et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II
HU Barthelmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Design and synthesis of fluorescent substrates for human tyrosyl-DNA phosphodiesterase I
MC Rideout et al.
NUCLEIC ACIDS RESEARCH (2004)
Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide
DR Davies et al.
CHEMISTRY & BIOLOGY (2003)
Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures
DR Davies et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy
H Takashima et al.
NATURE GENETICS (2002)
Kinetic studies of human tyrosyl-DNA phosphodiesterase, an enzyme in the topoisomerase I DNA repair pathway
TJ Cheng et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily
H Interthal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Modulation of RNA function by aminoglycoside antibiotics
R Schroeder et al.
EMBO JOURNAL (2000)
分享论文
